VBA
TECH icon

Van Berkom & Associates’s Bio-Techne TECH Stock Holding History

Van Berkom & Associates’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-21,341
Closed -$1.19M – 73
2025
Q3 		$1.19M Hold
21,341
– – 0.03% 53
2025
Q2 		$1.1M Buy
21,341
+5,702
+36% +$287K 0.03% 53
2025
Q1 		$917K Sell
15,639
-4,493
-22% -$304K 0.03% 56
2024
Q4 		$1.45M Sell
20,132
-652
-3% -$47.9K 0.04% 52
2024
Q3 		$1.66M Buy
20,784
+545
+3% +$41K 0.05% 50
2024
Q2 		$1.45M Hold
20,239
– – 0.04% 52
2024
Q1 		$1.43M Sell
20,239
-197
-1% -$14.1K 0.04% 54
2023
Q4 		$1.58M Buy
20,436
+2,530
+14% +$167K 0.05% 49
2023
Q3 		$1.22M Sell
17,906
-1,299
-7% -$103K 0.04% 54
2023
Q2 		$1.57M Buy
19,205
+1,563
+9% +$126K 0.06% 52
2023
Q1 		$1.31M Buy
+17,642
New +$1.36M 0.05% 57

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Van Berkom & Associates's TECH Position: Q4 2025 in Review

Van Berkom & Associates sold out of Bio-Techne (TECH) in Q4 2025, closing a stake of 21,341 shares — an estimated $1.19M sold.

Van Berkom & Associates first reported a position in TECH in Q1 2023 and held it in 11 quarters. The position peaked at $1.66M in Q3 2024. 585 funds tracked by Wall St. Rank hold TECH as of Q4 2025.

  • Van Berkom & Associates reported no remaining Bio-Techne position as of Q4 2025 after selling out during the quarter.
  • Van Berkom & Associates sold 21,341 Bio-Techne shares in Q4 2025, an estimated $1.19M.
  • Van Berkom & Associates first reported a position in Bio-Techne in Q1 2023 and held it in 11 quarters.
  • Van Berkom & Associates's Bio-Techne position peaked at $1.66M in Q3 2024.
  • 585 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2025.

Based on Van Berkom & Associates's 13F filing for Q4 2025, filed 2 Feb 2026.